End-of-day quote
Other stock markets
|
||
- GBX | - |
May. 10 | StanChart exec sells shares; new Alphawave CFO buys | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 4.81B 6.11B | Sales 2025 * | 4.99B 6.34B | Capitalization | 1.96B 2.49B |
---|---|---|---|---|---|
Net income 2024 * | 152M 193M | Net income 2025 * | 163M 207M | EV / Sales 2024 * | 0.54 x |
Net Debt 2024 * | 618M 784M | Net Debt 2025 * | 505M 642M | EV / Sales 2025 * | 0.49 x |
P/E ratio 2024 * |
13.4
x | P/E ratio 2025 * |
11.7
x | Employees | - |
Yield 2024 * |
2.18% | Yield 2025 * |
2.53% | Free-Float | 98% |
Latest transcript on Serco Group plc
Managers | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Nigel Crossley
DFI | Director of Finance/CFO | 61 | 13-12-31 |
Paul Checketts
IRC | Investor Relations Contact | - | 20-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Irwin
CEO | Chief Executive Officer | 59 | 13-03-31 |
Lynne Peacock
BRD | Director/Board Member | 70 | 17-06-30 |
John Rishton
CHM | Chairman | 66 | 16-09-12 |
1st Jan change | Capi. | |
---|---|---|
+14.85% | 70.23B | |
+5.12% | 17.08B | |
+12.12% | 13.77B | |
+20.33% | 13.57B | |
+16.67% | 10.15B | |
-19.27% | 7.04B | |
-1.15% | 6.18B | |
+3.30% | 5.27B | |
+1.07% | 5.06B |